ArticleAsian journal of andrology

Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy.

Mo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.